Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial

Open Access

Peer-reviewed

Research Article

Seiji Sato,

Affiliation Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
⨯
Yoshifumi Saisho ,

* E-mail: ysaisho@z5.keio.jp

Affiliation Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
⨯
Kinsei Kou,

Affiliation Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
⨯
Shu Meguro,

Affiliation Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
⨯
Masami Tanaka,

Affiliation Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
⨯
Junichiro Irie,

Affiliation Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
⨯
Toshihide Kawai,

Affiliation Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
⨯
Hiroshi Itoh

Affiliation Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
⨯

Reader Comments (0)

Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
HbA1c
Is the Subject Area "HbA1c" applicable to this article?

Thanks for your feedback.
Hypoglycemia
Is the Subject Area "Hypoglycemia" applicable to this article?

Thanks for your feedback.
Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Glucagon
Is the Subject Area "Glucagon" applicable to this article?

Thanks for your feedback.
Type 2 diabetes
Is the Subject Area "Type 2 diabetes" applicable to this article?

Thanks for your feedback.
Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Physicians
Is the Subject Area "Physicians" applicable to this article?

Thanks for your feedback.